Pyridam Farma Tbk PT
IDX:PYFA
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Moody's Corp
NYSE:MCO
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
S
|
Seritage Growth Properties
NYSE:SRG
|
Real Estate
|
| US |
|
Freeport-McMoRan Inc
NYSE:FCX
|
Metals & Mining
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| KR |
|
Coupang Inc
NYSE:CPNG
|
Retail
|
| CA |
|
Teck Resources Ltd
NYSE:TECK
|
Metals & Mining
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
KBR Inc
NYSE:KBR
|
Professional Services
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Micron Technology Inc
NASDAQ:MU
|
Semiconductors
|
| US |
|
T-Mobile US Inc
NASDAQ:TMUS
|
Telecommunication
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89
1 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Moody's Corp
NYSE:MCO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
S
|
Seritage Growth Properties
NYSE:SRG
|
US |
|
|
Freeport-McMoRan Inc
NYSE:FCX
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Coupang Inc
NYSE:CPNG
|
KR |
|
|
Teck Resources Ltd
NYSE:TECK
|
CA |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
KBR Inc
NYSE:KBR
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Micron Technology Inc
NASDAQ:MU
|
US |
|
|
T-Mobile US Inc
NASDAQ:TMUS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Long-Term Investments
Pyridam Farma Tbk PT
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Long-Term Investments
Rp99.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Long-Term Investments
Rp45.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-5%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Long-Term Investments
Rp454.8B
|
CAGR 3-Years
36%
|
CAGR 5-Years
38%
|
CAGR 10-Years
28%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Long-Term Investments
Rp37.9B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
24%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Long-Term Investments
Rp3.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Long-Term Investments
Rp1.1T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
21%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Long-Term Investments?
Long-Term Investments
99.7B
IDR
Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Long-Term Investments amounts to 99.7B IDR.
What is Pyridam Farma Tbk PT's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
57%
Over the last year, the Long-Term Investments growth was -1%. The average annual Long-Term Investments growth rates for Pyridam Farma Tbk PT have been 57% over the past three years .
You don't have any saved screeners yet
